Meningitis News and Research

Latest Meningitis News and Research

Health workers to get mumps booster in battle against the spread of the disease

The outbreak of mumps which is currently rife in parts of Canada has prompted Health officials to make 40,000 doses of a mumps booster available to health workers across Nova Scotia.

14 May 2007

Mumps makes a comeback Canada

Health officials in Canada are concerned about an outbreak of mumps which appears to be spreading.

7 May 2007

Serious illness among children with sickle cell disease reduced with pneumococcal conjugate vaccine

A vaccine introduced in 2000 has reduced by more than 90 percent the rate of a serious bacterial illness among young children with sickle cell disease (SCD), who are particularly susceptible to it, according to a new study that appears in the June 1 issue of Clinical Infectious Diseases and currently is available online.

2 May 2007

A need to assess risks involved with spinal manipulation in children

Researchers are calling for the creation of a collaborative registry to assess the risk of serious injuries when treating children using spinal manipulation.

27 Apr 2007

Increase in pneumococcal infections not covered by childhood vaccine

Alaskan native children are experiencing increased rates of serious infections caused by strains of pneumococcal bacteria that are not covered by the current childhood pneumococcal vaccine, indicating the importance of ongoing surveillance of vaccine effectiveness, according to a study in the current issue of JAMA.

25 Apr 2007

USAID provides assistance to Burkina Faso for outbreak of meningitis

The United States Government, through the U.S. Agency for International Development (USAID), will provide $450,000 through the U.S. Embassy in Ouagadougou to the UN Children's Fund (UNICEF) for vaccines urgently needed to maintain control of an outbreak of meningitis.

15 Apr 2007

India is poised to revolutionize biotechnology

India's health biotech firms are emerging as a major global player, with growing means and know-how to produce innovative as well as generic drugs and vaccines at costs small relative to those of giant Western firms, according to ground-breaking Canadian research.

10 Apr 2007

Need for a national database of epidural complications

Researchers have called for a national database to be set up to identify major complications arising from epidural pain relief after a small number of serious problems were identified during a six-year UK study, according to the April issue of Anaesthesia.

4 Apr 2007

Cochlear implants increase risk of bacterial infections that can cause meningitis

Confirming what physicians have long speculated, a new study published in the April edition of Otolaryngology-Head and Neck Surgery determines that the presence of cochlear implants increases the risk of bacterial infections that can cause meningitis in recipients.

3 Apr 2007

PCV7 vaccine reduces frequent ear infections in children

A vaccine has been shown to help reduce the number of infants and toddlers developing frequent ear infections, according to new research from Katherine A. Poehling, M.D., a pediatrician at Brenner Children's Hospital, part of Wake Forest University Baptist Medical Center.

2 Apr 2007

Scientists uncover bacterial cloaking

Scientists have uncovered the workings of a method bacteria responsible for diseases such as meningitis and blood disorders use to hide from the body's immune system.

2 Apr 2007

GlaxoSmithKline files European meningococcal conjugate vaccine

GlaxoSmithKline has announced the submission of a regulatory file to European Medicines Agency (EMEA) under Article 58 for the combination vaccine candidate Globorix (diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b, Neisseria meningitides serogroups A and C).

1 Apr 2007

FDA clears Xpert EV test for meningitis

The U.S. Food and Drug Administration (FDA) has cleared for marketing a test that uses molecular biology to quickly detect the presence of viral meningitis.

19 Mar 2007

FDA approves Soliris (eculizumab), first treatment for paroxysmal nocturnal hemoglobinuria

The U.S. Food and Drug Administration (FDA) has approved Soliris (eculizumab), the first product for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare type of blood disorder that can lead to disability and premature death.

19 Mar 2007

15,595 meningitis cases this season in Africa

Two months into the dry season in the African "Meningitis Belt", 15,595 cases including 1,670 deaths have been reported to the World Health Organization (WHO) from four countries: Burkina Faso, the Democratic Republic of the Congo, Sudan and Uganda.

19 Mar 2007

Vaccines for measles-mumps-rubella and varicella are effective in extremely preterm infants

The study, which included 16 term and 16 extremely preterm (born before about 6 months of pregnancy) infants born between May 2002 and May 2005, is the first of its kind to examine the antibody levels of measles, mumps, rubella and varicella in this population before and after vaccination. It was published in this month's Pediatrics.

5 Mar 2007

FDA approval for new cattle antibiotic will cause controversy

According to reports the Food and Drug Administration (FDA) in the United States is about to approve the use of another antibiotic in cattle.

4 Mar 2007

One billion battling with neurological disorders

According to a new report by the World Health Organization (WHO), neurological disorders ranging from migraines to epilepsy and dementia, affect up to 1 billion people worldwide and that number is destined to rise as populations age.

1 Mar 2007

Neurological disorders a global problem

A new report from the World Health Organization (WHO) shows that neurological disorders, ranging from epilepsy to Alzheimer disease, from stroke to headache, affect up to one billion people worldwide. Neurological disorders also include brain injuries, neuroinfections, multiple sclerosis and Parkinson disease.

27 Feb 2007

Scientists identify specific enzymes that make meningitis hard to fight

Two enzymes in meningitis bacteria which prevent the body from successfully fighting off the disease, and make the infection extremely virulent, have been identified in new research published today.

22 Feb 2007